
Citadel takes £305m short position in GSK
Citadel, the multi-strategy hedge fund major founded by Ken Griffin, has taken a £305m ($384.5m) short position in GSK, which equates to 0.515 of the British pharmaceutical giant’s stock, according to a report by the Financial Times.
